The availability of safe and effective oral direct-acting antivirals (DAAs) has paved the path to eliminating hepatitis C (HCV) infection. Accordingly, the World Health Organisation (WHO) addressed a global target in 2016 for the elimination of HCV ...

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Essentially, persistent hepatitis B virus (HBV) infection is one of the most important risk factors for HCC1. Thus, targeted strategies to mitigate HBV ...

Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders in children, with an estimated global prevalence of 5–7% in school-aged children. It is characterised by hyperactivity and impulsivity with ...

“The current progress of HCV elimination in Hong Kong is a bit left behind, yet latest strategies and policy have loosen access criteria for Direct-Acting Antiviral (DAA) therapies, making it possible for Hong Kong to catch up with other count...

"The current progress of HCV elimination in Hong Kong is a bit left behind, yet latest strategies and policy have loosen access criteria for Direct-Acting Antiviral (DAA) therapies, making it possible for Hong Kong to catch up with other countr...

Current Efforts on HCV Elimination in Hong Kong “There is still a long way to go if Hong Kong were to achieve the WHO goal by 2030,” commented Dr. Mak. Indeed, a retrospective study by Hui et al (2018) involving 11,309 anti-HCV positive ...

Broken Linkage to Care According to the World Health Organization (WHO), globally there were less than 5% of hepatitis C virus (HCV)-infected patients who received an HCV diagnosis whereas less than 1% received HCV treatment 1 . Recently, Hui et al ...